Determination of the lumped constant for [18F]fluorodeoxyglucose in human skeletal muscle

Journal of Nuclear Medicine

Volumn 40, Issue 11, 1999, Pages 1798-1804

  Kelley, David E ^a   Williams, Katherine V ^b   Price, Julie C ^b   Goodpaster, Bret ^b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

Deoxyglucose; Insulin sensitivity; Lumped constant; PET; Skeletal muscle; 18F fluorodeoxyglucose

Indexed keywords

DEOXYGLUCOSE; FLUORODEOXYGLUCOSE; HEXOKINASE; INSULIN;

ADULT; ARTICLE; BINDING AFFINITY; FEMALE; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HUMAN; HUMAN EXPERIMENT; INSULIN RESISTANCE; MALE; MUSCLE METABOLISM; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SKELETAL MUSCLE;

EID: 0032692930     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Schmidt KC, Lucignani G, Sokoloff L. Fluorine-18-fluorodeoxyglucose PET to determine regional cerebral glucose utilization: a re-examination. J Nucl Med. 1996;37:394-399.
2. Phelps ME, Huang SC, Hoffman EJ, Selin CE, Sokoloff L, Kuhl DE. Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-d-glucose: validation of method. Ann Neurol. 1979;6:371-388.
3. Voipio-Pulkki LM, Nuutila P, Knuuti J, et al. Heart and skeletal muscle glucose disposal in type 2 diabetic patients as determined by positron emission tomography. J Nucl Med. 1993;34:2064-2067.
4. Ng CK, Soufer R, McNulty PH. Effect of hyperinsulinemia on myocardial flourine-18-FDG uptake. J Nucl Med. 1998;39:379-383.
5. Kelley DE, Mintun MA, Watkins SC, et al. The effect of non-insulin-dependent diabetes mellitus and obesity on glucose transport and phosphorylation in skeletal muscle. J Clin Invest. 1996;97:2705-2713
6. Nuutila P, Knuuti MJ, Maki M, et al. Gender and insulin sensitivity in the heart and in skeletal muscles: studies using positron emission tomography. Diabetes. 1995;44:31-36.
7. Selberg O, Burchert W, Hoff JVD, et al. Insulin resistance in liver cirrhosis: positron-emission tomography scan analysis of skeletal muscle glucose metabolism. J Clin Invest. 1993;91:1897-1902.
8. Nuutila P, Raitakari M, Laine H, et al. Role of blood flow in regulating insulin-stimulated glucose uptake in humans. J Clin Invest. 1996;97:1741-1747.
9. Kelley DE, Mokan M, Mandarino LJ. Intracellular defects in glucose metabolism in obese patients with NIDDM. Diabetes. 1992;41:698-706.
10. Bonadonna RC, Del Prato S, Bonora E, et al. Roles of glucose transport and glucose phosphorylation in muscle insulin resistance of NIDDM. Diabetes. 1996;45:915-925.
11. Rothman DL, Magnusson I, Cline G, et al. Decreased muscle glucose transport/ phosphorylation is an early defect in the pathogenesis of non-imulin-dependent diabetes mellitus. Proc Natl Acad Sci USA. 1995;92:983-987.
12. Friedman JE, Caro JF, Pories WJ, Azevedo JL, Dohm GL. Glucose metabolism in incubated human muscle: effect of obesity and non-insulin-dependent diabetes mellitus. Metabolism. 1994;43:1047-1054.
13. Nuutila P, Kinisto VA, Knwuti J, et al. Glucose-free fatty acid cycle operates in human heart and skeletal muscle in vivo. J Clin Invest. 1992;89:1767-1774.
14. Raitakari M, Nuutila P, Ruotsalainen U, et al. Evidence for dissociation of insulin stimulation of blood flow and glucose uptake in human skeletal muscle. Diabetes. 1996;45:1471-1477.
15. Crane PD, Pardridge WM, Braun LD, Oldendorf WH. Kinetics of transport and phosphorylation of 2-fluoro-2-deoxy-D-glucose in rat brain. J Neurochem. 1983;40:160-167.
16. Bessell EM, Foster AB, Westwood JH. The use of deoxyfluoro-D-glucopyranoses and related compounds in a study of yeast hexokinase specificity. Biochem J. 1972;128:199-204.
17. 11C]deoxyglucose. J Cereb Blood Flow Metab. 1985;5:179-192.
18. 14C]-2-deoxy-d-glucose method for measuring local cerebral glucose utilization. Mathematical analysis and determination of the "lumped" constants. Neurosci Res Prog Bull. 1976;14:466-468.
19. 14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J Neurochem. 1977;28:897-916.
20. Williams G, Wilding J. The central nervous system and diabetes mellitus. In: Pickup JC, Williams G, eds. Textbook of Diabetes. 2nd ed. Cambridge, MA: Blackwell Science, Inc.; 1997;65.1-65.30.
21. Cranston I, Marsden P, Matyka K, et al. Regional differences in cerebral blood flow and glucose utilization in diabetic man: the effect of insulin. J Cereb Blood Flow Metab. 1998;18:130-140.
22. Gjedde A, Wienhard K, Heiss W, et al. Comparative regional analysis of 2-fluorodeoxyglucose and methylglucose uptake in brain of four stroke patients with special reference to regional estimation of the lumped constant. J Cereb Blood Flow Metab. 1985;5:163-178.
23. Crane PD, Pardridge WM, Braun LD, Nyerges AM, Oldendorf WH. The interaction of transport and metabolism on brain glucose utilization: a reevaluation of the lumped constant. J Neurochem. 1981;36:1601-1604.
24. 18F]fluorodeoxyglucose. J Nucl Cardiol. 1997;4:125-132.
25. Russell RR, Mrus JM, Mommessin JL, Taegtmeyer H. Compartmentation of hexokinase in rat heart. A critical factor for tracer kinetic analysis of myocardial glucose metabolism. J Clin Invest. 1992;90:1972-1977.
26. Mossberg KA, Rowe RW, Tewson TJ, Taegtmeyer H. Rabbit hindlimb glucose uptake assessed with positron emitting fluorodeoxyglucose. J Appl Physiol. 1989;67:1569-1577.
27. Ferre P, Leturque A, Burnol A, Penicaud L, Girard J. A method to quantify glucose utilization in vivo in skeletal muscle and white adipose tissue of the anesthetized rat. Biochem J. 1985;228:103-110.
28. Burnol A, Ferre P, Leturque A, Girard J. Effect of insulin on in vivo glucose utilization in individual tissues of anesthetized lactating rats. Am J Physiol. 1987;252:E183-E188.
29. 18]fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution. J Nucl Med. 1986;27:235-238.
30. Wolfe RR. Glucose metabolism. In: Wolfe RR. Radioactive and Stable Isotope Tracers in Biomedicine: Principles and Practice of Kinetic Analysis. New York, NY: Wiley-Liss; 1992:283-316.
31. Colberg SR, Simoneau JA, Thaete FL, Kelley DE. Skeletal muscle utilization of free fatty acids in women with visceral obesity. J Clin Invest. 1993;95:1846-1853.
32. Barnes D, Egan G. O'Keefe G, Abbott D. Characterization of dynamic 3-D PET imaging for functional brain mapping. IEEE Trans Med Imaging. 1997;16:261-269.
33. Bailey DL, Young H, Bloomfield PM, et al. ECAT ART-a continuously rotating PET camera: performance characteristics, initial clinical studies, and installation considerations in a nuclear medicine department. Eur J Nucl Med. 1997;24:6-15.
34. Watson CC, Newport D, Casey ME. A single scatter simulation technique for scatter correction in 3-D PET. In: Proceedings of the 1995 International Meeting on Fully Three-Dimensional Image Reconstruction in Radiology and Nuclear Medicine. Dordrecht, The Netherlands: Kluwer Academic Publishers; 1995;215-219.
35. Patlak CS, Blasberg RG. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metab. 1985 ;5:584-590.
36. Zierler K. Theory of the use of arteriovenous concentration differences for measuring metabolism in steady and non-steady states. J Clin Invest. 1961;40:2111-2125.
37. Handberg A, Vaag A, Vinten J, Beck-Nielsen H. Decreased tyrosine kinase activity in partially purified insulin receptors from muscle of young, non-obese first degree relatives of patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia. 1993;36:668-674.
38. Kelley DE, Reilly JP, Veneman T, Mandarino LJ. Effects of insulin on skeletal muscle glucose storage, oxidation, and glycolysis in humans. Am J Physiol. 1990;258:E923-E929.
39. Yki-Jarvinen H, Young A, Lamkin C, Foley JE. Kinetics of glucose disposal in whole body and across skeletal muscle in man. J Clin Invest. 1987;79:1713-1719.
40. Wilson JE. Hexokinases. Rev Physiol Biochem Pharmacol. 1995; 126:65-198.